About
PregnanTech is developing the Lioness, a small, disposable device designed to maintain the natural resistance of the cervix in order to prevent preterm birth. The Lioness is positioned around the uterine cervix and behaves like a shock absorber, allowing transient shortening and dilation of the cervix during contractions and then restoring the cervix to its initial state when contractions subside. The device is inserted by a physician during an outpatient visit and removed at term. PregnanTech has conducted a range of successful preclinical studies and in 2019 began a clinical safety study of Lioness among non-pregnant women intended for hysterectomy. Initial findings demonstrate the significant potential inherent in the device. Professor Kypros Nicolaides, a preeminent obstetrician from Kings College Hospital in London, has expressed his interest in leading a first clinical trial in 2021 among pregnant women at risk of preterm birth. PregnanTech is part of the Trendlines Group.
Funding history · 4 rounds · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is PregnanTech's primary focus?
- PregnanTech is developing the Lioness, a small, disposable device designed to prevent preterm birth by maintaining the natural resistance of the cervix.
- When was PregnanTech founded?
- PregnanTech was founded in January 2017.
- What is the status of PregnanTech's clinical studies for the Lioness device?
- PregnanTech began a clinical safety study of the Lioness device in 2019 among non-pregnant women. Initial findings have demonstrated significant potential. Professor Kypros Nicolaides from Kings College Hospital in London expressed interest in leading a first clinical trial in 2021 among pregnant women at risk of preterm birth.
- Which organization is PregnanTech part of?
- PregnanTech is part of the Trendlines Group.
- Who were the investors in PregnanTech's February 2017 Seed round?
- In February 2017, PregnanTech received Seed funding from Sheba Medical Center and The Trendlines Group.
- When did PregnanTech conduct an equity crowdfunding round?
- PregnanTech conducted an equity crowdfunding round in August 2020 with ExitValley as an investor.
- Who invested in PregnanTech's February 2023 Seed round?
- In February 2023, 4T Ventures invested in PregnanTech's Seed round.
- What was PregnanTech's most recent funding round?
- PregnanTech's most recent funding round was an Undisclosed Round in January 2026, with Longliv Ventures as an investor.
- How many employees does PregnanTech currently have?
- PregnanTech currently has 8 employees.
- Who are the co-founders of PregnanTech?
- The co-founders of PregnanTech are David Shashar and Avi Tsur.